Mammalian hyaluronidase induces ovarian granulosa cell apoptosis and is involved in follicular atresia.
During ovarian folliculogenesis, the vast majority of follicles will undergo atresia by apoptosis, allowing a few dominant follicles to mature. Mammalian hyaluronidases comprise a family of six to seven enzymes sharing the same catalytic domain responsible for hyaluronan hydrolysis. Interestingly, some of these enzymes have been shown to induce apoptosis. In the ovary, expression of three hyaluronidases (Hyal-1, Hyal-2, and Hyal-3) has been documented. However, their precise cellular localization and role in ovarian regulation have not yet been defined. We herein investigated the possible involvement of these enzymes in ovarian atresia. First, we established a mouse model for ovarian atresia (gonadotropin withdrawal by anti-equine chorionic gonadotropin treatment) and showed that the mRNA levels of Hyal-1, Hyal-2, and Hyal-3 were significantly increased in apoptotic granulosa cells as well as in atretic follicles. Second, using ovaries of normally cycling mice, we demonstrated the correlation of Hyal-1 mRNA and protein expression with cleavage of caspase-3. In addition, we showed that expression of all three hyaluronidases induced apoptosis in transfected granulosa cells. Significantly, the induction of apoptosis by hyaluronidases was independent of catalytic activity, because enzymatically inactive Hyal-1 mutant (D157A/E159A) was as efficient as the wild-type enzyme in apoptosis induction. The activation of the extrinsic apoptotic signaling pathway was involved in this induction, because increased levels of cleaved caspase-8, caspase-3, and poly-ADP-ribose polymerase (PARP) were observed upon hyaluronidase ectopic expression. Our present findings provide a better understanding of the role of hyaluronidases in ovarian functions, showing for the first time their involvement in follicular atresia.
Orimoto
Adriana M
AM
Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada H1T 2M4.
Dumaresq-Doiron
Karine
K
Jiang
Jin-Yi
JY
Tanphaichitr
Nongnuj
N
Tsang
Benjamin K
BK
Carmona
Euridice
E
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics*; D053148:Caspase 3 / Q000378:metabolism; D053181:Caspase 8 / Q000378:metabolism; D030762:Estrous Cycle / Q000235:genetics / Q000378:metabolism; D005260:Female; D005496:Follicular Atresia / Q000235:genetics* / Q000378:metabolism; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006064:Gonadotropins, Equine / Q000276:immunology; D006107:Granulosa Cells / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D006821:Hyaluronoglucosaminidase / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D008297:Male; D008322:Mammals / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism
D000906:Antibodies; D006064:Gonadotropins, Equine; D011065:Poly(ADP-ribose) Polymerases; D006821:Hyaluronoglucosaminidase; D053148:Caspase 3; D053181:Caspase 8